Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allakos Inc.

0.3269
+0.00060.18%
Volume:410.09K
Turnover:134.05K
Market Cap:29.54M
PE:-0.25
High:0.3286
Open:0.3263
Low:0.3261
Close:0.3263
Loading ...

Company Profile

Company Name:
Allakos Inc.
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
131
Office Location:
825 Industrial Road,Suite 500,San Carlos,California,United States
Zip Code:
94070
Fax:
- -
Introduction:
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.

Directors

Name
Position
Robert Alexander
President, Chief Executive Officer and Director
Daniel S. Janney
Chair of the Board
John McKearn
Director
Paul Walker
Director
Robert E. Andreatta
Director
Steven P. James
Director

Shareholders

Name
Position
Robert Alexander
President, Chief Executive Officer and Director
Adam Tomasi
Chief Operating Officer, Chief Financial Officer and Secretary
Henrik Rasmussen
Chief Medical Officer